Volume 24, Issue 4-5 396281 pp. 257-266
Article
Open Access

Lung Cancer Stem Cells

Sharon R. Pine

Sharon R. Pine

Center for Cancer Research NCI NIH Bethesda, MD, USA

Search for more papers by this author
Blair Marshall

Blair Marshall

Georgetown University Washington DC, USA , georgetown.edu

Search for more papers by this author
Lyuba Varticovski

Corresponding Author

Lyuba Varticovski

Center for Cancer Research NCI NIH Bethesda, MD, USA

Search for more papers by this author
First published: 21 May 2008
Citations: 29

Abstract

Lung cancer remains a major cause of cancer-related lethality because of high incidence and recurrence in spite of significant advances in staging and therapies. Recent data indicates that stem cells situated throughout the airways may initiate cancer formation. These putative stem cells maintain protumorigenic characteristics including high proliferative capacity, multipotent differentiation, drug resistance and long lifespan relative to other cells. Stem cell signaling and differentiation pathways are maintained within distinct cancer types, and destabilization of this machinery may participate in maintenance of cancer stem cells. Characterization of lung cancer stem cells is an area of active research and is critical for developing novel therapies. This review summarizes the current knowledge on stem cell signaling pathways and cell markers used to identify the lung cancer stem cells.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.